---
granola_id: fd283628-a883-4f59-bf76-d4453fae2804
title: "Virtue <> Squad Health"
type: note
created: 2025-05-30T13:59:41.144Z
updated: 2025-05-30T16:42:24.271Z
attendees:
  - manav@squadhealth.ai
  - mallika@squadhealth.ai
  - sd@virtuevc.com
---
### Company Background & Evolution

- Summer '22: Goal of starting company was to enable specialty practices, particularly independent specialty pharmacy practices
- Spent 2023 focused on value-based care (VBC) - concluded either no business opportunity or wrong founder fit
- Pivoted to navigation, billing new navigation codes in 2024 - billing insurance on behalf of providers and taking a cut
- #1 provider request was prescription navigation
- Brought in Manav from Stripe to build technology platform for:
	- Prior authorization (PA)
	- Pharmacy routing
	- Financial assistance
- Changed business model to free platform for providers, monetize through manufacturers

### Team & Traction

- Manavâ€™s background:
	- Google APM program
	- Stripe for 4 years - grew from $20M to $1B+ in origination
	- Built fraud suite (RADAR) - expanded to multiple payment methods, new countries
	- Focus on ML-first products
- Current adoption metrics:
	- 100 providers onboarded in May 2024
	- 500-600 providers in pipeline
	- Under NDA with first pharma manufacturer
- Unique provider-first lens drives product strategy and market approach

### Product & Technology

- Provider integration:
	- Up and running within couple of days
	- Only requires username/login credentials
	- Uses AI for automation - no traditional integration needed
- Workflow:
	- Providers send script to non-dispensing pharmacy
	- System automatically checks PA requirements
	- Grabs clinical notes from EHR
	- Completes PA form and manages appeals
	- Identifies appropriate pharmacy for filling
	- Includes co-pay assistance capabilities
- AI capabilities:
	- Answers complex semantic questions
	- Generates appeal letters
	- Manages end-to-end workflow
- Target market: Independent providers
	- 50% Urology (entry point into oncology)
	- 50% GI
	- Expanding to Rheumatology

### Manufacturer Strategy

- Benefits of manufacturer sponsorship:
	- Improved appeal letter generation
	- Drug-specific workflow optimization
	- Model refinement through PA feedback
- Prior auth is not end goal - focused on driving scripts
- Free provider offering bridges regulatory gap
- Key metrics tracked:
	- PA submission rates (100% unless clinical note missing)
	- PA approval rates
	- Fill rates

### Fundraising

- Raising seed round of $4-6M
- Use of funds: Scale NPI network over next 12-18 months
- Seeking investors who:
	- Deeply understand healthcare
	- Can accelerate provider relationships (primary)
	- Can facilitate manufacturer connections (secondary)
- Starting formal process next week with initial materials

Chat with meeting transcript: https://notes.granola.ai/d/fd283628-a883-4f59-bf76-d4453fae2804
